⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8915740 | 1.00 | — | — | |
| SCHEMBL4386057 | 0.69 | — | — | |
| SCHEMBL4386054 | 0.69 | — | — | |
| SCHEMBL5709669 | 0.69 | — | — | |
| SCHEMBL15739022 | 0.67 | — | — | |
| SCHEMBL12143376 | 0.67 | — | — | |
| SCHEMBL11010702 | 0.60 | — | — | |
| SCHEMBL40167 | 0.59 | — | — | |
| SCHEMBL6337059 | 0.59 | — | — | |
| Methyl Alcohol SCHEMBL4870551 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106110311-A | Blood coagulation protein conjugates | 百深公司 | 2016-11-16 | — | — | CN | claimed |
| EP-4094778-B1 | POLYMER LINKERS AND THEIR USES | NOVACYTE THERAPEUTICS COMPANY LTD (CN) | 2024-05-15 | — | — | EP | disclosed |
| US-20230119152-A1 | POLYMER LINKERS AND THEIR USES | NOVACYTE THERAPEUTICS COMPANY., LTD (CN) | 2023-04-20 | — | — | US | disclosed |
| US-20230119152-A1 | POLYMER LINKERS AND THEIR USES | NOVACYTE THERAPEUTICS COMPANY., LTD (CN) | 2023-04-20 | — | — | US | disclosed |
| US-11529422-B2 | Polymer linkers and their uses | NOVACYTE THERAPEUTICS COMPANY., LTD (CN) | 2022-12-20 | — | — | US | disclosed |
| US-11529422-B2 | Polymer linkers and their uses | NOVACYTE THERAPEUTICS COMPANY., LTD (CN) | 2022-12-20 | — | — | US | disclosed |
| CN-113194999-A | NaPi2 b-targeted polymeric antibody-drug conjugates and methods of use thereof | 梅尔莎纳医疗公司 | 2021-07-30 | — | — | CN | disclosed |
| US-20200155693-A1 | POLYMER LINKERS AND THEIR USES | NOVACYTE, INC. (US) | 2020-05-21 | — | — | US | disclosed |
| US-20200155693-A1 | POLYMER LINKERS AND THEIR USES | NOVACYTE, INC. (US) | 2020-05-21 | — | — | US | disclosed |
| US-10583196-B2 | Polymer linkers and their uses | NOVACYTE, INC. (US) | 2020-03-10 | — | — | US | disclosed |
| CN-105979970-B | Protein-polymer-drug conjugate | 梅尔莎纳医疗公司 | 2019-09-10 | — | — | CN | disclosed |
| EP-3464400-A1 | POLYMER LINKERS AND THEIR USES | Novacyte, Inc. (US) | 2019-04-10 | — | — | EP | disclosed |
| EP-3464400-A1 | POLYMER LINKERS AND THEIR USES | Novacyte, Inc. (US) | 2019-04-10 | — | — | EP | disclosed |
| US-20190083634-A1 | POLYMER LINKERS AND THEIR USES | NOVACYTE, INC. (US) | 2019-03-21 | — | — | US | disclosed |
| US-20190083634-A1 | POLYMER LINKERS AND THEIR USES | NOVACYTE, INC. (US) | 2019-03-21 | — | — | US | disclosed |
| WO-2017210566-A1 | POLYMER LINKERS AND THEIR USES | NOVACYTE, INC. (US) | 2017-12-07 | — | — | WO | disclosed |
| WO-2017210566-A1 | POLYMER LINKERS AND THEIR USES | NOVACYTE, INC. (US) | 2017-12-07 | — | — | WO | disclosed |
| CN-106110311-A | Blood coagulation protein conjugates | 百深公司 | 2016-11-16 | — | — | CN | disclosed |
| CN-105979970-A | Protein-polymer-drug conjugates | 梅尔莎纳医疗公司 | 2016-09-28 | — | — | CN | disclosed |
| CN-105008530-A | Thrombin sensitive coagulation factor X molecules | NOVO NORDISK AS | 2015-10-28 | — | — | CN | disclosed |